Zydus Lifesciences Q3 Results

  • BSE: 532321
  • NSE: ZYDUSLIFE
  • ISIN: INE010B01027
  • Sector: Biotechnology & Drugs
BSE
964.5-29.55 (-2.97%)
Volume32.46 K
Updated: Fri 12 Apr, 2024 | 15:29:54
NSE
962.15-32.05 (-3.22%)
Volume1.33 M
Updated: Fri 12 Apr, 2024 | 15:55:07
Today: 958.50
997.15
52-Wk: 482.55
1,031.30

Q3 Results Highlights

  • Total Income
    ₹4,505.20 Cr.
    (3.28%)
  • Operating Profit
    ₹887.00 Cr.
    (14.54%)
  • Profit After Tax
    ₹767.80 Cr.
    (23.34%)
  • Operating Margin
    19.69%
    (10.91%)
Note: Comparison is on YoY basis

Quarterly - Zydus Lifesciences Q3 Results

*All figures in crores except per share values
Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
Total Revenue 4,505.204,368.803.12%4,362.303.28%
Selling/ General/ Admin Expenses Total 817.30752.908.55%689.0018.62%
Depreciation/ Amortization 194.80184.205.75%181.607.27%
Other Operating Expenses Total 1,137.601,078.205.51%1,206.90-5.74%
Total Operating Expense 3,618.203,489.103.70%3,587.900.84%
Operating Income 887.00879.700.83%774.4014.54%
Net Income Before Taxes 925.501,007.20-8.11%780.1018.64%
Net Income 789.60800.70-1.39%622.9026.76%
Diluted Normalized EPS 7.587.92-4.23%6.1523.41%

Recommended For You

    More From Recommended

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe